Key statistics
On Friday, IRadimed Corp (46K:FRA) closed at 43.60, -0.46% below its 52-week high of 43.80, set on Sep 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 43.60 |
---|---|
High | 43.60 |
Low | 43.60 |
Bid | 43.60 |
Offer | 44.40 |
Previous close | 42.80 |
Average volume | 0.00 |
---|---|
Shares outstanding | 12.67m |
Free float | 7.98m |
P/E (TTM) | 32.80 |
Market cap | 607.90m USD |
EPS (TTM) | 1.46 USD |
Annual div (ADY) | 0.5391 EUR |
---|---|
Annual div yield (ADY) | 1.24% |
Div ex-date | Aug 20 2024 |
Div pay-date | Aug 30 2024 |
Data delayed at least 15 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Announcements
- IRADIMED CORPORATION To Participate in the Lake St. Annual Best Ideas Growth “Big 8” Investor Conference
- IRADIMED CORPORATION Announces Second Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
- IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Conference Call on August 1st
- IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
- IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
- IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
- IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
- IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
- IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
- IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
More ▼